The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come.
The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute to the campus’ world-class scientific talent, ecosystem and related facilities, including the Research Complex at Harwell and the new Rosalind Franklin Institute.
Company Details
- Employees
- 25
- Address
- Research Complex At Harwell, Rutherford Appleton Laboratory Harwell,united Kingdom
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- natahub.org
- HQ
- Harwell Science Campus, UK
Nata - Nucleic Acid Therapy Accelerator Questions
Nata - Nucleic Acid Therapy Accelerator's website is natahub.org
Nata - Nucleic Acid Therapy Accelerator's LinkedIn profile is https://uk.linkedin.com/company/natahub
Nata - Nucleic Acid Therapy Accelerator has
25 employees.
View email and phone details for 25
employees at Nata - Nucleic Acid Therapy Accelerator.
Nata - Nucleic Acid Therapy Accelerator's industry is
Research Services
Nata - Nucleic Acid Therapy Accelerator's top competitors are
Mary Lyon Centre At Mrc Harwell,
Medical Research Council,
Rna Therapeutics And Oligonucleotides,
Oligotune,
Taylorollinson Ltd,
Research Complex At Harwell,
Oligonova Hub,
Uk Research And Innovation,
Rosalind Franklin Institute,
Oligonucleotide Therapeutics Society.
Nata - Nucleic Acid Therapy Accelerator's categories are Research Services
